Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BCL2 G101V
i
Other names:
BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
596
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BCL2 G101V
Chronic Lymphocytic Leukemia
BCL2 G101V
Chronic Lymphocytic Leukemia
venetoclax + rituximab
Resistant: C3 – Early Trials
venetoclax + rituximab
Resistant
:
C3
venetoclax + rituximab
Resistant: C3 – Early Trials
venetoclax + rituximab
Resistant
:
C3
BCL2 G101V
Chronic Lymphocytic Leukemia
BCL2 G101V
Chronic Lymphocytic Leukemia
venetoclax + obinutuzumab
Resistant: C3 – Early Trials
venetoclax + obinutuzumab
Resistant
:
C3
venetoclax + obinutuzumab
Resistant: C3 – Early Trials
venetoclax + obinutuzumab
Resistant
:
C3
BCL2 G101V
Chronic Lymphocytic Leukemia
BCL2 G101V
Chronic Lymphocytic Leukemia
BGB-11417
Sensitive: D – Preclinical
BGB-11417
Sensitive
:
D
BGB-11417
Sensitive: D – Preclinical
BGB-11417
Sensitive
:
D
BCL2 G101V
Chronic Lymphocytic Leukemia
BCL2 G101V
Chronic Lymphocytic Leukemia
venetoclax
Resistant: D – Preclinical
venetoclax
Resistant
:
D
venetoclax
Resistant: D – Preclinical
venetoclax
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login